Literature DB >> 12050147

Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels.

Beth L Roman1, Van N Pham, Nathan D Lawson, Magdalena Kulik, Sarah Childs, Arne C Lekven, Deborah M Garrity, Randall T Moon, Mark C Fishman, Robert J Lechleider, Brant M Weinstein.   

Abstract

The zebrafish mutant violet beauregarde (vbg) can be identified at two days post-fertilization by an abnormal circulation pattern in which most blood cells flow through a limited number of dilated cranial vessels and fail to perfuse the trunk and tail. This phenotype cannot be explained by caudal vessel abnormalities or by a defect in cranial vessel patterning, but instead stems from an increase in endothelial cell number in specific cranial vessels. We show that vbg encodes activin receptor-like kinase 1 (Acvrl1; also known as Alk1), a TGFbeta type I receptor that is expressed predominantly in the endothelium of the vessels that become dilated in vbg mutants. Thus, vbg provides a model for the human autosomal dominant disorder, hereditary hemorrhagic telangiectasia type 2, in which disruption of ACVRL1 causes vessel malformations that may result in hemorrhage or stroke. Movies available on-line

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050147     DOI: 10.1242/dev.129.12.3009

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  150 in total

Review 1.  Vascularization of the developing chick limb bud: role of the TGFbeta signalling pathway.

Authors:  Neil Vargesson
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

2.  CDP-diacylglycerol synthetase-controlled phosphoinositide availability limits VEGFA signaling and vascular morphogenesis.

Authors:  Weijun Pan; Van N Pham; Amber N Stratman; Daniel Castranova; Makoto Kamei; Kameha R Kidd; Brigid D Lo; Kenna M Shaw; Jesus Torres-Vazquez; Constantinos M Mikelis; J Silvio Gutkind; George E Davis; Brant M Weinstein
Journal:  Blood       Date:  2012-05-30       Impact factor: 22.113

3.  Patterning mechanisms of the sub-intestinal venous plexus in zebrafish.

Authors:  Michela Goi; Sarah J Childs
Journal:  Dev Biol       Date:  2015-10-22       Impact factor: 3.582

4.  Rspo1/Wnt signaling promotes angiogenesis via Vegfc/Vegfr3.

Authors:  Aniket V Gore; Matthew R Swift; Young R Cha; Brigid Lo; Mary C McKinney; Wenling Li; Daniel Castranova; Andrew Davis; Yoh-suke Mukouyama; Brant M Weinstein
Journal:  Development       Date:  2011-10-17       Impact factor: 6.868

Review 5.  Bone Morphogenetic Protein functions as a context-dependent angiogenic cue in vertebrates.

Authors:  David M Wiley; Suk-Won Jin
Journal:  Semin Cell Dev Biol       Date:  2011-10-12       Impact factor: 7.727

6.  Combinatorial function of ETS transcription factors in the developing vasculature.

Authors:  Van N Pham; Nathan D Lawson; Joshua W Mugford; Louis Dye; Daniel Castranova; Brigid Lo; Brant M Weinstein
Journal:  Dev Biol       Date:  2006-10-25       Impact factor: 3.582

Review 7.  Veins and Arteries Build Hierarchical Branching Patterns Differently: Bottom-Up versus Top-Down.

Authors:  Kristy Red-Horse; Arndt F Siekmann
Journal:  Bioessays       Date:  2019-03       Impact factor: 4.345

8.  pak2a mutations cause cerebral hemorrhage in redhead zebrafish.

Authors:  David A Buchner; Fengyun Su; Jennifer S Yamaoka; Makoto Kamei; Jordan A Shavit; Linda K Barthel; Beth McGee; Julio D Amigo; Seongcheol Kim; Andrew W Hanosh; Pudur Jagadeeswaran; Daniel Goldman; Nathan D Lawson; Pamela A Raymond; Brant M Weinstein; David Ginsburg; Susan E Lyons
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-22       Impact factor: 11.205

9.  Endoglin moves and shapes endothelial cells.

Authors:  Victoria L Bautch
Journal:  Nat Cell Biol       Date:  2017-05-31       Impact factor: 28.824

10.  UBIAD1-mediated vitamin K2 synthesis is required for vascular endothelial cell survival and development.

Authors:  Jeffrey M Hegarty; Hongbo Yang; Neil C Chi
Journal:  Development       Date:  2013-04       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.